Lipodystrophy & Metabolic Complications: Treatment
- Tesamorelin Growth-Hormone Releaser Reduces Liver Fat in People With HIV (March 7, 2014)
From HIVandHepatitis.com
- Theratechnologies Withdraw EU Application for Tesamorelin (Egrifta) (July/August 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- HIV/AIDS and Lipodystrophy Treatments Part III: Treatments for Metabolic Changes (May 2012)
From The Well Project
- HIV/AIDS and Lipodystrophy Treatments Part I: Treatments for Fat Gain (May 2012)
From The Well Project
- New Treatment for Excess Deep Belly Fat Approved (February 2011)
To read PDF, click here.
In Project Inform Perspective, from Project Inform
- Metabolic Marker Changes Similar After 12 Weeks of Darunavir and Atazanavir (July 26, 2010)
From National AIDS Treatment Advocacy Project
- Raltegravir vs. Efavirenz: Focus on Lipodystrophy, Lipids and Other Changes (June 30, 2010)
To read PDF, click here.
In Treatment Update, from Canadian AIDS Treatment Information Exchange
On TheBodyPRO.com
- Medicare Expands Coverage for Treating Facial Lipodystrophy Syndrome in People Living With HIV (March 23, 2010)
From Project Inform
- Rosiglitazone Analysis Sparks Safety Controversy (May 22, 2007)
From aidsmap.com
On TheBodyPRO.com
- Banishing Chipmunk Cheeks and Bullfrog Neck (September/October 2006)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- Exercise and Body Fat Changes (April 20, 2006)
From aidsmap.com
- IAS: Exercise of Benefit for Lipodystrophy (August 8, 2005)
From aidsmap.com
- Human Growth Hormone Under Study as Lipodystrophy Treatment (March 2005)
In WISE Words, from Project Inform
- Treatment Options for Lipodystrophy (Lipoatrophy, Lipohypertrophy and Hyperlipidemia) (March 2005)
In WISE Words, from Project Inform
- Treating Morphologic and Metabolic Complications in HIV-Infected Patients on Antiretroviral Therapy (February 2005)
Consensus statement from an advisory committee of the International Association of Physicians in AIDS Care.
To read PDF, click here.
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- Rosiglitazone Reduces Lipoatrophy, Hyperinsulinemia in HIV-Infected Patients, Study Finds (May 19, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
On TheBodyPRO.com
- Rosiglitazone Ups and Downs (October 2003)
From the 2nd International AIDS Society Conference.
In HIV Treatment ALERTS!, from The Center for AIDS
- Metabolic Complications: A Look at the IAS Guidelines (Spring 2003)
To read PDF, click here.
In ACRIA Update, from AIDS Community Research Initiative of America
- Retrovirus 2003: Management of Metabolic Complications (February 14, 2003)
In The 10th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- The Many Faces of Human Growth Hormone (Winter 2002/2003)
To read PDF, click here.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
On TheBodyPRO.com
- Summary of IAS-USA Recommendations for the Management of Metabolic Complications (November 26, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from CDC National Prevention Information Network
|
Advertisement
|
Email
Glossary
